Back to search
FDAFDA · Food and drugs·Recall number D-0295-2024

Leader brand Dry Eye Relief (Polyethylene glycol 400 0.4% and Propylene glycol 0.3%) packaged in 0.33 FL OZ (10 mL) bottles, Distributed by Cardinal Health Dublin, Ohio 43017, NDC 70000-0088-1

Published February 14, 2024 · Recall initiated: November 13, 2023

Summary

FDA records drug Class I recall D-0295-2024, published February 14, 2024 and initiated November 13, 2023. Recalling firm: Kilitch Healthcare India Limited; Status: Ongoing; Reported quantity: 12,960 bottles; Lot: All lots. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Non-Sterility

What to do

Voluntary: Firm initiated · Press Release

Get an email if DRY EYE RELIEF has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DRY EYE RELIEF
Manufacturer
Kilitch Healthcare India Limited
Distributor
Nationwide within the United States
Lot
All lots
Risk classification
Class I
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Leader brand Dry Eye Relief (Polyethylene glycol 400 0.4% and Propylene glycol 0.3%) packaged in 0.33 FL OZ (10 mL) bottles, Distributed by Cardinal Health Dublin, Ohio 43017, NDC 70000-0088-1 recalled?

Yes. FDA published recall D-0295-2024 on February 14, 2024. Reported hazard: Non-Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DRY EYE RELIEF.